Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

The Worldwide Genetic Toxicology Testing Industry is Expected to Reach $2.4 Billion by 2028 at a 13.2% CAGR

DUBLIN, Jan. 27, 2023 /PRNewswire/ -- The "Global Genetic Toxicology Testing Market Size, Share & Industry Trends Analysis Report by Product, Type, Application (Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry), Regional Outlook and Forecast, 2022-2028" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo


The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the forecast period.

The genetic toxicology testing research and observes the consequences of numerous physical, biological, and chemical substances on the heredity of live creatures. Genetic toxicology is the study of the harmful outcomes of DNA damage. These examinations are carried out either to detect chromosomal damage or gene mutation.

Agrochemicals, pharmaceutical impurities, chemicals utilized in the cosmetics industry, pharmaceutical medications, and industrial chemicals are all subjected to toxicological studies. Genetic toxicology is a crucial component of research and development (R&D), where novel medications are developed and designed through a variety of studies. These tests aid in the development of novel medications and vaccinations.

These studies also concentrate on in vitro drug discovery and tailored pharmaceuticals. In addition to these applications, there is a growing need for humanized animal models, which will present a plethora of chances for the major competitors in the genetic toxicology testing market. Testing for genetic toxicity has a variety of uses in the cosmetics, food, pharmaceutical, and biotech industries.

The requirement for genetic toxicology information is predicted to increase due to the increased medication research and discovery as well as the expanding usage of pharmacogenomics. This is because it can evaluate the substances that can cause chromosomal damage or genetic alterations. A significant growth factor in the genetic toxicity testing field is also the development of facilities and the availability of funding globally.

COVID-19 Impact Analysis

Due to lockdowns that have halted manufacturing operations and enforced travel restrictions, affecting the transit of shipments, the rapid expansion of COVID-19 has resulted in a lack of medical equipment and supplies. COVID-19 has not severely affected the availability of raw materials used in genetic toxicology, with the exception of transportation-related delays brought on by travel restrictions and labor scarcity difficulties.

Toxicology research was being conducted to comprehend the virus mutation. Similar to this, many researchers used genotoxic to evaluate how well medications worked on the COVID-19 virus. Therefore, it can be said that the pandemic had a positive impact on the genetic toxicology testing market.

Market Growth Factors

Rising investments in pharmaceutical R&D by companies

By raising the adoption of substances in the preclinical phases, R&D operations primarily aim to raise the overall likelihood of acceptance of Phase I therapeutic candidates. In the initial stages of medication development, intense R&D activities are carried out to accomplish this. The necessity for genetic toxicology research is consequently increased. Before a medicine enters the pricey clinical stages, higher R&D expenditures in the early phases of drug products are also anticipated to enhance the usage of in vivo toxicity techniques.

Increasing demand for humanized methods of in vivo testing including animals

More and more biomedical research applications use humanized mice as test subjects. Professors at Yale University and the Jackson Laboratory (US) were awarded a three-year grant in 2017 to perform advanced research on humanized MISTRG models for understanding the biology of human melanoma along with identifying therapeutic targets. The Connecticut Bioscience Innovation Fund (CBIF) awarded the Jackson Laboratory and Yale University (US) a grant in the amount of USD 700,000 in November 2018. This award supported scientific collaboration to create humanized mouse models that correctly reflect how people react to disease and cancer treatments.

Marketing Restraining Factor:

Insufficient verified in vitro models for complex endpoint research

Given that human proteins and antibodies make over half of the novel medications created, autoimmune disease and immunological activation are crucial endpoints for drug development. These medicinal compounds can only yet be tested in animal models. The use of in vitro genetic toxicology testing techniques does not permit the assessment of the response induced within a body following secondary infection. These techniques can't assess how well a body recovers in response to short-term versus long-term immunosuppression.

Report Attribute


No. of Pages


Forecast Period

2021 - 2028

Estimated Market Value (USD) in 2021

$1018 Million

Forecasted Market Value (USD) by 2028

$2388 Million

Compound Annual Growth Rate

13.2 %

Regions Covered



Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Genetic Toxicology Testing Market

Chapter 4. Global Genetic Toxicology Testing Market by Product
4.1 Global Services Market by Region
4.2 Global Reagents & Consumables Market by Region
4.3 Global Assays Market by Region

Chapter 5. Global Genetic Toxicology Testing Market by Type
5.1 Global In Vitro Market by Region
5.2 Global In Vivo Market by Region

Chapter 6. Global Genetic Toxicology Testing Market by Application
6.1 Global Pharmaceutical & Biotechnology Market by Region
6.2 Global Food Industry Market by Region
6.3 Global Cosmetics Industry Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Genetic Toxicology Testing Market by Region

Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Eurofins Scientific Group
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Recent Strategies and Developments Acquisition and Mergers
8.3 Laboratory Corporation of America Holdings
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Recent Strategies and Developments Acquisition and Mergers
8.4 Charles River Laboratories International, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent Strategies and Developments Partnerships, Collaborations, and Agreements Acquisition and Mergers
8.5 Jubilant Pharmova Limited
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Syngene International Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.7 Gentronix Ltd.
8.7.1 Company Overview
8.7.2 Recent Strategies and Developments Acquisition and Mergers
8.8 Inotiv, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent Strategies and Developments Acquisition and Mergers
8.9 Creative Bioarray
8.9.1 Company Overview
8.10. MB Research Laboratories
8.10.1 Company Overview

For more information about this report visit https://www.researchandmarkets.com/r/480qdk-genetic?w=5

Media Contact: Laura Wood | +353-1-481-1716 | press@researchandmarkets.net

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

These press releases may also interest you

at 01:00
CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri...

at 00:01
As infectious disease outbreaks and extreme weather events threaten the health of more Americans, a new report shows the need for strengthened national and state public health emergency preparedness....

22 mar 2023
The biodegradable packaging materials market size is estimated to grow by USD 30,958.3 million from 2022 to 2027. The growth momentum of the market will accelerate at a CAGR of 6.03%, according to Technavio. The report also includes a detailed...

22 mar 2023
The "Research Antibodies and Reagents Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the...

22 mar 2023
The "Healthcare E-Commerce Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The...

22 mar 2023
The "Smart Wearables Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global...

News published on 27 january 2023 at 14:10 and distributed by: